Trinity Biotech plc
TRIB
$0.94
$0.022.51%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 09/30/2023 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 58.65M | 59.13M | 69.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 58.65M | 59.13M | 69.37M |
| Cost of Revenue | -- | -- | 38.55M | 38.87M | 49.29M |
| Gross Profit | -- | -- | 20.10M | 20.26M | 20.08M |
| SG&A Expenses | -- | -- | 28.54M | 33.89M | 23.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -112.00K | -482.00K | 2.94M |
| Total Operating Expenses | -- | -- | 71.35M | 76.71M | 79.57M |
| Operating Income | -- | -- | -12.69M | -17.58M | -10.21M |
| Income Before Tax | -- | -- | -22.14M | -41.85M | -35.37M |
| Income Tax Expenses | -- | -- | 155.00K | -69.00K | -1.37M |
| Earnings from Continuing Operations | -- | -- | -22.29 | -41.78 | -34.00 |
| Earnings from Discontinued Operations | -- | -- | -4.00K | 13.19M | 1.81M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -22.30M | -28.60M | -32.20M |
| EBIT | -- | -- | -12.69M | -17.58M | -10.21M |
| EBITDA | -- | -- | -11.16M | -15.63M | -9.26M |
| EPS Basic | -- | -- | -53.64 | -74.09 | -108.08 |
| Normalized Basic EPS | -- | -- | -0.30 | -0.56 | -0.53 |
| EPS Diluted | -- | -- | -54.16 | -73.96 | -108.06 |
| Normalized Diluted EPS | -- | -- | -0.30 | -0.56 | -0.53 |
| Average Basic Shares Outstanding | -- | -- | 33.66M | 29.70M | 23.51M |
| Average Diluted Shares Outstanding | -- | -- | 1.68M | 1.48M | 1.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |